Compare GALT & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | GRVY |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.3M | 473.7M |
| IPO Year | 2008 | 2005 |
| Metric | GALT | GRVY |
|---|---|---|
| Price | $3.49 | $66.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 197.8K | 16.3K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $54.54 |
| 52 Week High | $7.13 | $76.00 |
| Indicator | GALT | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 46.20 |
| Support Level | $2.71 | $65.90 |
| Resistance Level | $3.56 | $69.12 |
| Average True Range (ATR) | 0.23 | 1.18 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 41.34 | 65.49 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. The gaming products of the company include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation. Geographically, it derives maximum revenue from Taiwan.